Tirzepatide 10mg

Description

Tirzepatide 10mg is a synthetic peptide that acts as a dual agonist of the GIP and GLP-1 receptors, two important signaling pathways involved in glucose metabolism, insulin response, appetite, and energy balance.

The compound has become one of the most extensively studied members of the modern incretin category. By activating both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, tirzepatide provides researchers with a model for studying how simultaneous incretin signaling influences metabolic regulation.

Research involving tirzepatide has examined glucose-dependent insulin secretion, appetite signaling, energy intake, body-weight regulation, cardiometabolic markers, and other metabolic pathways.

Common research areas: GIP signaling, GLP-1 signaling, glucose metabolism, insulin signaling, appetite regulation, metabolic function, and body-weight regulation.

Product Strength: 10mg

Tirzepatide itself is an FDA-approved active ingredient in prescription products. Mounjaro is approved for type 2 diabetes, while Zepbound has approvals related to chronic weight management and moderate-to-severe obstructive sleep apnea in adults with obesity. A separately sold 10mg research vial should not be represented as Mounjaro or Zepbound.